How much is Kernalbio worth in 2026?

Kernalbio has a current valuation of N/A based on their Later Stage VC (Series A) round and secondary market data.

How much funding has Kernalbio raised?

Kernalbio has raised N/A in total funding across 1 funding rounds.

Kernalbio

Drug Discovery

Current Valuation

N/A

As of July 7, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series A)

$25.0M

Last Funding

Jul 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Interested in buying or selling Kernalbio shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
July 7, 2022	Later Stage VC (Series A)	$25.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Kernalbio is currently valued at N/A as of July 7, 2022.

Explore More Data

Detailed analysis for Kernalbio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

What is Kernalbio Worth in 2026?

Kernalbio is a leading private company in the Drug Discovery sector. Track Kernalbio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Kernalbio Valuation is Determined

Private company valuations like Kernalbio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.